This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Amgen CEO Robert Bradway scored $24.4 million in total compensation last year, h...
Aurobindo's Aurolife Pharma has received a Form 483 from the FDA outlining 11 ob...
In a Friday speech to FDA employees, the HHS secretary laid bare his belief that...
Sandoz has filed an antitrust lawsuit in federal court in Virginia claiming that...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
If you ever find yourself doing outdoor hobbies in slow motion or bursting into ...
Despite President Donald Trump’s threat last week that tariffs on pharmaceutical...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
Gilead Sciences’ sponsorship of a conference Wi-Fi network has landed it in hot ...
The HIV-focused biopharma has received its latest bid from CDMO Future Pak for a...
Is your pharmacy strategy limiting success? Discover how outdated models impact ...
The drug won an accelerated approval last year in extensive-stage small cell lun...
Bristol Myers Squibb has received the FDA’s green light to compete with Roche's ...
After years of back-and-forth with the FDA over Hetlioz's potential use as a jet...
The HHS secretary is leading the charge of a "massive testing and research drive...
Already thriving with a successful launch of infused Vyvgart and its subcutaneou...
After Pfizer let limited patient interest get the best of its hemophilia B gene ...
A special congressional committee has recommended a $15 billion investment to bo...
As work continues on a new biologics plant in the U.S., Kyowa Kirin has complete...
PhRMA's latest ad highlights the double trouble that can come from pharmacy bene...
As concerns around President Donald Trump's import tariffs mount, Novartis has a...
After the success of a public service advertisement campaign aimed at improving ...
After the success of a public service advertisement campaign aimed at improving ...
Merck has handed out another hefty raise to CEO Rob Davis, boosting his compensa...